Skip to content

Evaluation of Efficacy and Technology Promotion of Moxibustion in Improving akinetic–rigid Parkinson's Disease

Evaluation of the therapeutic effect of the penetrating-needle technique in improving akinetic–rigid Parkinson's disease and its technical promotion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001713
Enrollment
Unknown
Registered
2026-07-09
Start date
2026-07-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Acupuncture group:Acupuncture
Sham acupuncture gruop:Sham acupuncture

Sponsors

Ruian Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of akinetic–rigid Parkinson's disease; (2) The disease stage was in the early or middle stage; (3) age 40-80 years old; (4) in a relatively stable stage, taking dopamine efficacy drugs regularly with no change or no medication in the past 1 month;

Exclusion criteria

Exclusion criteria: (1) patients with severe allergic constitution or allergy to stainless steel acupuncture needles or sterilized cotton swabs used in the intervention; (2) patients with serious primary diseases of the heart, liver, kidney, hematopoietic system and other important organs and systems requiring treatment. (3) patients with neurological or mental disorders who were unable to cooperate or unwilling to cooperate. (4) pregnant or lactating women and those with recent childbearing plans.

Design outcomes

Primary

MeasureTime frame
Movement Disorder Society Unified Parkinson's Disease Rating Scale;

Secondary

MeasureTime frame
Time and step distance required to walk 20 m;Purdue Plate Experiment;Ashworth scale score ;

Countries

China

Contacts

Public ContactLin Faqu

Ruian Hospital of Traditional Chinese Medicine

332077593@qq.com13706889976

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026